NEW ORLEANS, LA—Recombinant factor VIIa slowed hematoma growth in patients with a spontaneous intracerebral hemorrhage (ICH) when administered within 2 hours of onset, but treatment significantly ...

Imagine a life-saving spray that instantly stops severe bleeding. That’s exactly what researchers in South Korea have developed — and it could change how wounds are treated on the battlefield, and in ...

NEW ORLEANS -- There is still hope that recombinant factor VIIa (rFVIIa) may be a good hemostatic treatment for acute intracerebral hemorrhage (ICH) under the right circumstances -- just not the way ...

Proteolysis targeting chimeras (PROTACs) represent a promising strategy for targeted protein degradation, yet optimizing their pharmacokinetic properties remains challenging. Here, the authors develop ...

Abstract: This paper proposes an ultrasonic scalpel based on the longitudinal-torsional vibration mode to enhance the hemostatic ability. The concentrator of the proposed ultrasonic scalpel has been ...

Platelets, non-nucleated blood components first described over 130 years ago, are recognized as the primary cell regulating hemostasis and thrombosis. The vascular importance of platelets has been ...

The title should be concise, omitting terms that are implicit and, where possible, be a statement of the main result or conclusion presented in the manuscript. Abbreviations should be avoided within ...

Jan. 16, 2026 A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening cancer vaccines. Scientists have now developed a drug that shuts ...

Commentary Applied Biological Sciences Harnessing hemostasis to transform surgical scars into CAR-T immunological niches Xiao Cheng and Ke Cheng [email protected] Authors Info & Affiliations ...

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.